Ketamine and depression

Br J Anaesth. 2018 Dec;121(6):1198-1202. doi: 10.1016/j.bja.2018.08.020. Epub 2018 Oct 12.

Authors

K Hirota¹, D G Lambert²

Affiliations

¹ Department of Anesthesiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. Electronic address: [email protected].
² University Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, Leicester Royal Infirmary, Leicester, UK.

PMID: 30442244
DOI: 10.1016/j.bja.2018.08.020

No abstract available

Publication types

Editorial

MeSH terms

Anti-Inflammatory Agents / pharmacology
Antidepressive Agents / pharmacology*
Catecholamines / metabolism
Depression / drug therapy
Humans
Ketamine / adverse effects
Ketamine / pharmacology*
Ketamine / therapeutic use
Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors

Substances

Anti-Inflammatory Agents
Antidepressive Agents
Catecholamines
Receptors, N-Methyl-D-Aspartate
Ketamine